FDA Recommends Collaboration, Parallel Development Of Patient-Reported Outcome Tools
Executive Summary
A new draft guidance document from the US agency on the development of instruments to measure patient-reported outcomes offers a range of approaches to improve the efficiency and quality of these important tools.